Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer. | Breast Cancer Res | 2022 | 35659359 | PubTator, text mining | PubMed |
| YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. | Nat Commun | 2022 | 35654829 | PubTator, text mining | PubMed |
| A role for microfluidic systems in precision medicine. | Nat Commun | 2022 | 35654785 | PubTator, text mining | PubMed |
| Potential biomarkers and molecular mechanisms in preeclampsia progression. | Open Life Sci | 2022 | 35647297 | PubTator, text mining | PubMed |
| Inhibition of the sodium-dependent HCO3- transporter SLC4A4, produces a cystic fibrosis-like airway disease phenotype. | Elife | 2022 | 35635440 | PubTator, text mining | PubMed |
| Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy. | Pharmaceutics | 2022 | 35631699 | PubTator, text mining | PubMed |
| Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis. | Pharmaceuticals (Basel) | 2022 | 35631371 | PubTator, text mining | PubMed |
| Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline-Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. | Pharmaceuticals (Basel) | 2022 | 35631321 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer. | Biomedicines | 2022 | 35625741 | PubTator, text mining | PubMed |
| Pnictogen-Centered Cascade Exchangers for Thiol-Mediated Uptake: As(III)-, Sb(III)-, and Bi(III)-Expanded Cyclic Disulfides as Inhibitors of Cytosolic Delivery and Viral Entry. | JACS Au | 2022 | 35615714 | PubTator, text mining | PubMed |
| Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model. | Comput Math Methods Med | 2022 | 35607647 | PubTator, text mining | PubMed |
| Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer. | Oxid Med Cell Longev | 2022 | 35592530 | PubTator, text mining | PubMed |
| Comprehensive Analysis Identified the Circadian Clock and Global Circadian Gene Expression in Human Corneal Endothelial Cells. | Invest Ophthalmol Vis Sci | 2022 | 35579906 | PubTator, text mining | PubMed |
| Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors. | Eur J Med Chem | 2022 | 35551035 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma. | Transl Vis Sci Technol | 2022 | 35536719 | PubTator, text mining | PubMed |
| The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX. | J Enzyme Inhib Med Chem | 2022 | 35535546 | PubTator, text mining | PubMed |
| The identification of miRNA and mRNA expression profiles associated with pediatric atypical teratoid/rhabdoid tumor. | BMC Cancer | 2022 | 35524230 | PubTator, text mining | PubMed |
| Non-gynaecological Applications of Menstrual-derived Stem Cells: A Systematic Review. | Avicenna J Med Biotechnol | 2022 | 35509365 | PubTator, text mining | PubMed |
| Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. | J Enzyme Inhib Med Chem | 2022 | 35506234 | PubTator, text mining | PubMed |
| Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer. | NPJ Breast Cancer | 2022 | 35501337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=20